Numab's Pipeline To Benefit From Intarcia Licensing Its ND016

 
• By Sten Stovall
  
Nerve cells
Numab develops next-generation multispecific antibody-based immunotherapies • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Deals

More from Business